Market movement
In 2024, amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (inn), methadone (inn), and normethadone (inn) and salts thereof trade exhibited significant decline, with global flows reaching $176,376,524 and a three-year compound annual growth rate of +0.2% (five-year: -1.9%). The all-time peak of $194,927,498 was recorded in 2003; the current level is 10% below that high-water mark.
Over the 30-year observation window (1995–2024), 59% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is steady (+0.2% acceleration).
